These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22708752)

  • 1. Kissing goodbye to key opinion leaders.
    Moynihan RN
    Med J Aust; 2012 Jun; 196(11):671. PubMed ID: 22708752
    [No Abstract]   [Full Text] [Related]  

  • 2. Key opinion leaders: used as a marketing tool by drug companies.
    Prescrire Int; 2012 Jun; 21(128):163-5. PubMed ID: 22822596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical opinion leaders conflict of interests: effects of disclosures on the trust of the public and general practitioners].
    Chakroun R; Milhabet I
    Rev Epidemiol Sante Publique; 2011 Aug; 59(4):233-42. PubMed ID: 21757308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the drug industry work with key opinion leaders? Yes.
    Buckwell C
    BMJ; 2008 Jun; 336(7658):1404. PubMed ID: 18566075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the drug industry work with key opinion leaders? No.
    Fava GA
    BMJ; 2008 Jun; 336(7658):1405. PubMed ID: 18566076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following the script: how drug reps make friends and influence doctors.
    Fugh-Berman A; Ahari S
    PLoS Med; 2007 Apr; 4(4):e150. PubMed ID: 17455991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wisdom of the crowd.
    Nature; 2005 Nov; 438(7066):281. PubMed ID: 16292279
    [No Abstract]   [Full Text] [Related]  

  • 10. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
    Kyle GJ; Nissen L; Tett S
    Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Opinion Leaders - SMi's Second Conference Knowledge Leaders.
    Mason VL
    IDrugs; 2009 Dec; 12(12):770-3. PubMed ID: 19943219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most Australians believe that drug company payments influence doctors' decisions.
    Moynihan R
    BMJ; 2012 Feb; 344():e1076. PubMed ID: 22331321
    [No Abstract]   [Full Text] [Related]  

  • 13. Pain Medicine Ethics Forum: Key Opinion Leaders with Industry Conflicts of Interest Should Be Able to Hold Leadership Positions in Professional Medical Associations.
    Wallace MS
    Pain Med; 2016 Feb; 17(2):218. PubMed ID: 26814302
    [No Abstract]   [Full Text] [Related]  

  • 14. Ghostwriting: the importance of definition and its place in contemporary drug marketing.
    Matheson A
    BMJ; 2016 Aug; 354():i4578. PubMed ID: 27576493
    [No Abstract]   [Full Text] [Related]  

  • 15. The best companies bare all.
    Jacobs T
    Nat Biotechnol; 2004 Nov; 22(11):1363. PubMed ID: 15529156
    [No Abstract]   [Full Text] [Related]  

  • 16. Key opinion leaders: Thus are our medical meetings managed.
    Fugh-Berman A
    BMJ; 2008 Jul; 337(7662):a789. PubMed ID: 18632708
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical branding: identity, individuality, and illness.
    Greenslit N
    Mol Interv; 2002 Oct; 2(6):342-5. PubMed ID: 14993408
    [No Abstract]   [Full Text] [Related]  

  • 18. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key opinion leaders: where they come from and how that affects the drugs you prescribe.
    Meffert JJ
    Dermatol Ther; 2009; 22(3):262-8. PubMed ID: 19453351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking the use of physicians as hired expert lecturers.
    Mulla K; Shonubi A; Katarey D
    Ann Intern Med; 2015 Feb; 162(4):321. PubMed ID: 25686176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.